Liu, D., Dou, L., Li, W. (2025). Ruxolitinib combined with decitabine-intensified modified busulfan/cyclophosphamide conditioning regimen reduces relapse after allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia. Blood. https://doi.org/10.1182/blood-2025-5969